Direct Rx is recalling 16 bottles of Zonisamide (zonisamide) Capsules USP (100 mg), a medication used to treat seizures. This recall was initiated due to gaps and deviations in the Quality Control microbiology laboratory systems at the manufacturing site. No illnesses or injuries have been reported to date in connection with this specific batch.
Gaps in quality control systems mean the product may not meet all safety and purity standards, potentially affecting the medication's effectiveness or safety. While no injuries are reported, deviations in a microbiology lab can lead to concerns regarding potential contamination.
You have 2 options:
Packaged and Distributed By: Direct Rx Dawsonville, GA 30534; Manufactured for: Glenmark Pharmaceuticals Inc., USA.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.